A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)

References

• Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007; 7:79-94; PMID:17251915; http://dx.doi.org/10.1038/nrc2069
   PubMed Web of Science ®Google Scholar
• Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002; 3:639-50; PMID:12209124; http://dx.doi.org/10.1038/nrm908
   PubMed Web of Science ®Google Scholar
• Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003; 63:1256-72; PMID:12761335; http://dx.doi.org/10.1124/mol.63.6.1256
   PubMed Web of Science ®Google Scholar
• Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, Brown A, Rodriguez SS, Weller JR, Wright AC, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 2003; 100:4903-8; PMID:12679517; http://dx.doi.org/10.1073/pnas.0230374100
   PubMed Web of Science ®Google Scholar
• Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 2004; 172:2853-60; PMID:14978086; http://dx.doi.org/10.4049/jimmunol.172.5.2853
   PubMed Web of Science ®Google Scholar
• Murphy C, McGurk M, Pettigrew J, Santinelli A, Mazzucchelli R, Johnston PG, Montironi R, Waugh DJ. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res 2005; 11:4117-27; PMID:15930347; http://dx.doi.org/10.1158/1078-0432.CCR-04-1518
   PubMed Web of Science ®Google Scholar
• Wang B, Hendricks DT, Wamunyokoli F, Parker MI. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res 2006; 66:3071-7; PMID:16540656; http://dx.doi.org/10.1158/0008-5472.CAN-05-2871
   PubMed Web of Science ®Google Scholar
• Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, Tang H, Burdick MD, Sato M, Minna JD, et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 2006; 66:4198-207; PMID:16618742; http://dx.doi.org/10.1158/0008-5472.CAN-05-3842
   PubMed Web of Science ®Google Scholar
• Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, Xue F, Mercado-Uribe I, Huang J, Lin SH, et al. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res 2010; 16:3875-86; PMID:20505188; http://dx.doi.org/10.1158/1078-0432.CCR-10-0483
   PubMed Web of Science ®Google Scholar
• Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 2002; 110:1703-16; PMID:12464676; http://dx.doi.org/10.1172/JCI0215849
   PubMed Web of Science ®Google Scholar
• Olszyna DP, Florquin S, Sewnath M, Branger J, Speelman P, van Deventer SJ, Strieter RM, van der Poll T. CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. J Infect Dis 2001; 184:301-7; PMID:11443555
   PubMed Web of Science ®Google Scholar
• Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006; 12:317-23; PMID:16474398; http://dx.doi.org/10.1038/nm1361
   PubMed Web of Science ®Google Scholar
• Bakshi P, Margenthaler E, Reed J, Crawford F, Mullan M. Depletion of CXCR2 inhibits gamma-secretase activity and amyloid-beta production in a murine model of Alzheimer's disease. Cytokine 2011; 53:163-9; PMID:21084199; http://dx.doi.org/10.1016/j.cyto.2010.10.008
   PubMed Web of Science ®Google Scholar
• Cerretti DP, Kozlosky CJ, Vanden Bos T, Nelson N, Gearing DP, Beckmann MP. Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Mol Immunol 1993; 30:359-67; PMID:8384312; http://dx.doi.org/10.1016/0161-5890(93)90065-J
   PubMed Web of Science ®Google Scholar
• Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008; 7:339-57; PMID:18382464; http://dx.doi.org/10.1038/nrd2518
   PubMed Web of Science ®Google Scholar
• Hutchings CJ, Koglin M, Marshall FH. Therapeutic antibodies directed at G protein-coupled receptors. MAbs 2010; 2:594-606; PMID:20864805; http://dx.doi.org/10.4161/mabs.2.6.13420
   PubMed Web of Science ®Google Scholar
• Misumi S, Nakayama D, Kusaba M, Iiboshi T, Mukai R, Tachibana K, Nakasone T, Umeda M, Shibata H, Endo M, et al. Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challenge. J Immunol 2006; 176:463-71; PMID:16365439; http://dx.doi.org/10.4049/jimmunol.176.1.463
   PubMed Web of Science ®Google Scholar
• Zhang Y, Pool C, Sadler K, Yan HP, Edl J, Wang X, Boyd JG, Tam JP. Selection of active ScFv to G-protein-coupled receptor CCR5 using surface antigen-mimicking peptides. Biochemistry 2004; 43:12575-84; PMID:15449947; http://dx.doi.org/10.1021/bi0492152
   PubMed Web of Science ®Google Scholar
• Katancik JA, Sharma A, de Nardin E. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine 2000; 12:1480-8; PMID:11023662; http://dx.doi.org/10.1006/cyto.2000.0742
   PubMed Web of Science ®Google Scholar
• Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007; 318:1258-65; PMID:17962520; http://dx.doi.org/10.1126/science.1150577
   PubMed Web of Science ®Google Scholar
• Gautier A, Mott HR, Bostock MJ, Kirkpatrick JP, Nietlispach D. Structure determination of the seven-helix transmembrane receptor sensory rhodopsin II by solution NMR spectroscopy. Nat Struct Mol Biol 2010; 17:768-74; PMID:20512150
   PubMed Web of Science ®Google Scholar
• Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, Kobilka BK. Structure of the delta-opioid receptor bound to naltrindole. Nature 2012; 485:400-4; PMID:22596164; http://dx.doi.org/10.1038/nature11111
   PubMed Web of Science ®Google Scholar
• Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008; 322:1211-7; PMID:18832607; http://dx.doi.org/10.1126/science.1164772
   PubMed Web of Science ®Google Scholar
• Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010; 330:1066-71; PMID:20929726; http://dx.doi.org/10.1126/science.1194396
   PubMed Web of Science ®Google Scholar
• Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G-protein-coupled receptor target family. ChemMedChem 2006; 1:761-82; PMID:16902930; http://dx.doi.org/10.1002/cmdc.200600134
   PubMed Web of Science ®Google Scholar
• Ajuebor MN, Zagorski J, Kunkel SL, Strieter RM, Hogaboam CM. Contrasting roles for CXCR2 during experimental colitis. Exp Mol Pathol 2004; 76:1-8; PMID:14738862; http://dx.doi.org/10.1016/j.yexmp.2003.08.004
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Raimondo M, Woodward TA, Wallace MB, Gill KR, Tong Z, Burdick MD, Yang Z, Strieter RM, Hoffman RM, et al. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. Int J Cancer 2009; 125:1027-37; PMID:19431209; http://dx.doi.org/10.1002/ijc.24383
   PubMed Web of Science ®Google Scholar
• Wente MN, Keane MP, Burdick MD, Friess H, Buchler MW, Ceyhan GO, Reber HA, Strieter RM, Hines OJ. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 2006; 241:221-7; PMID:16458421; http://dx.doi.org/10.1016/j.canlet.2005.10.041
   PubMed Web of Science ®Google Scholar
• Bleicher KH, Green LG, Martin RE, Rogers-Evans M. Ligand identification for G-protein-coupled receptors: a lead generation perspective. Curr Opin Chem Biol 2004; 8:287-96; PMID:15183327; http://dx.doi.org/10.1016/j.cbpa.2004.04.008
   PubMed Web of Science ®Google Scholar
• Jimonet P, Jager R. Strategies for designing GPCR-focused libraries and screening sets. Curr Opin Drug Discov Devel 2004; 7:325-33; PMID:15216936
   PubMed Web of Science ®Google Scholar
• Howl J, Langel U, Hawtin SR, Valkna A, Yarwood NJ, Saar K, Wheatley M. Chimeric strategies for the rational design of bioactive analogs of small peptide hormones. Faseb J 1997; 11:582-90; PMID:9212082
   PubMed Web of Science ®Google Scholar
• Ja WW, Roberts RW. G-protein-directed ligand discovery with peptide combinatorial libraries. Trends Biochem Sci 2005; 30:318-24; PMID:15950876; http://dx.doi.org/10.1016/j.tibs.2005.04.001
   PubMed Web of Science ®Google Scholar
• Lee B, Sharron M, Montaner LJ, Weissman D, Doms RW. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A 1999; 96:5215-20; PMID:10220446; http://dx.doi.org/10.1073/pnas.96.9.5215
   PubMed Web of Science ®Google Scholar
• Ohno Y, Suda K, Masuko K, Yagi H, Hashimoto Y, Masuko T. Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1. Cancer Sci 2008; 99:1000-7; PMID:18294274; http://dx.doi.org/10.1111/j.1349-7006.2008.00770.x
   PubMed Web of Science ®Google Scholar
• Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, Ferro ES, Devi LA. Conformation state-sensitive antibodies to G-protein-coupled receptors. J Biol Chem 2007; 282:5116-24; PMID:17148456; http://dx.doi.org/10.1074/jbc.M609254200
   PubMed Web of Science ®Google Scholar
• Lecat S, Bucher B, Mely Y, Galzi JL. Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses. J Biol Chem 2002; 277:42034-48; PMID:12185075; http://dx.doi.org/10.1074/jbc.M203606200
   PubMed Web of Science ®Google Scholar
• Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 2002; 277:30429-35; PMID:12034720; http://dx.doi.org/10.1074/jbc.M200681200
   PubMed Web of Science ®Google Scholar
• Houimel M, Mazzucchelli L. Identification of biologically active peptides that inhibit binding of human CXCL8 to its receptors from a random phage-epitope library. J Leukoc Biol 2009; 85:728-38; PMID:19118103; http://dx.doi.org/10.1189/jlb.0608380
   PubMed Web of Science ®Google Scholar
• Bannert N, Craig S, Farzan M, Sogah D, Santo NV, Choe H, Sodroski J. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J Exp Med 2001; 194:1661-73; PMID:11733580; http://dx.doi.org/10.1084/jem.194.11.1661
   PubMed Web of Science ®Google Scholar
• Comerford I, Nibbs RJ. Post-translational control of chemokines: a role for decoy receptors? Immunol Lett 2005; 96:163-74; PMID:15585320; http://dx.doi.org/10.1016/j.imlet.2004.08.018
   PubMed Web of Science ®Google Scholar
• Mortier A, Gouwy M, Van Damme J, Proost P. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res 2011; 317:642-54; PMID:21146523; http://dx.doi.org/10.1016/j.yexcr.2010.11.016
   PubMed Web of Science ®Google Scholar
• Slootstra JW, Puijk WC, Ligtvoet GJ, Langeveld JP, Meloen RH. Structural aspects of antibody-antigen interaction revealed through small random peptide libraries. Mol Divers 1996; 1:87-96; PMID:9237197; http://dx.doi.org/10.1007/BF01721323
   PubMed Web of Science ®Google Scholar
• Timmerman P, Puijk WC, Meloen RH. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology. J Mol Recognit 2007; 20:283-99; PMID:18074397; http://dx.doi.org/10.1002/jmr.846
   PubMed Web of Science ®Google Scholar
• Fields CG, Lloyd DH, Macdonald RL, Otteson KM, Noble RL. HBTU activation for automated Fmoc solid-phase peptide synthesis. Pept Res 1991; 4:95-101; PMID:1815783
   PubMedGoogle Scholar
• Timmerman P, Beld J, Puijk WC, Meloen RH. Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces. Chembiochem 2005; 6:821-4; PMID:15812852; http://dx.doi.org/10.1002/cbic.200400374
   PubMed Web of Science ®Google Scholar
• Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996; 14:309-14; PMID:9630891; http://dx.doi.org/10.1038/nbt0396-309
   PubMed Web of Science ®Google Scholar
• Lloyd C, Lowe D, Edwards B, Welsh F, Dilks T, Hardman C, Vaughan T. Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. Protein Eng Des Sel 2009; 22:159-68; PMID:18974080; http://dx.doi.org/10.1093/protein/gzn058
   PubMed Web of Science ®Google Scholar
• Groves M, Lane S, Douthwaite J, Lowne D, Rees DG, Edwards B, Jackson RH. Affinity maturation of phage display antibody populations using ribosome display. J Immunol Methods 2006; 313:129-39; PMID:16730741; http://dx.doi.org/10.1016/j.jim.2006.04.002
   PubMed Web of Science ®Google Scholar
• Kristensen P, Winter G. Proteolytic selection for protein folding using filamentous bacteriophages. Fold Des 1998; 3:321-8; PMID:9806934; http://dx.doi.org/10.1016/S1359-0278(98)00044-3
   PubMedGoogle Scholar